[{"Assets_0_Q3_USD":171490000.0,"CommonStockSharesOutstanding_0_Q3_shares":12685326.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-40519000.0,"NetIncomeLoss_1_Q3_USD":-21910000.0,"NetIncomeLoss_3_Q3_USD":-55195000.0,"StockholdersEquity_0_Q3_USD":101672000.0,"Ticker":"ALBO","CIK":"1322505","name":"ALBIREO PHARMA, INC.","OfficialName":"Albireo Pharma Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688702712.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]